Last reviewed · How we verify
Intraoperative Periarticular Injection in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery (PAI in ACLR)
In this prospective, assessor-blinded, single-surgeon clinical trial, the goal was to validate the efficacy of PAI in aACLR surgery with a reduced opioid dose, while achieving similar pain relief with few adverse events. 300 patients who had undergone aACLR were randomly allocated to receive either a PAI or nPAI group. The primary outcome parameters were visual analogue scale (VAS) scores and cumulative morphine dose, through time. Secondary outcome parameters included drug-related adverse events.
Details
| Lead sponsor | Taipei Veterans General Hospital, Taiwan |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 288 |
| Start date | Sun Mar 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Anterior Cruciate Ligament (ACL) Tear
- Arthroscopic Anterior Cruciate Ligament Reconstruction
Interventions
- Periarticular injection
Countries
Taiwan